ENABLE BIOTECH

ENABLE Biotech aims to partner with companies from research to clinical stage to address specific challenges of manufacturing advanced therapies. We Offer: CMC EXPERTISE Team with specific expertise and capabilities in the field of CGT manufacturing, ensuring a smooth transition of manufacturing processes Sponsors don’t need to worry about completing CMC sections for regulatory approvals or considering the future clinical development requirements FLEXIBILITY Transparent collaboration on developing manufacturing and QA process, providing flexibility for future in-house production or tech transfer We focus on pre-clinical to Phase IIa production, but sponsors will be equipped to make the transition to a phase-adapted CDMO or their own facility when the time is right SPEED Available capacity in SwissMedic accredited GMP facility R&D and manufacturing suites, avoiding delays to First in Human Easy shipment between patients in Europe and the manufacturing facility AFFORDABILITY Attractive costs for affordable therapies through use of existing facility Minimizing costs without compromising quality or timelines through efficient resource utilization Custom fee-for-service pricing models Contact us to learn more about how ENABLE BioTech can become YOUR next-generation CDMO. contact@enablebiotech.com